Capstone Asset Management’s Bristol-Myers Squibb BMY Stock Holding History

Capstone Asset Management’s Portfolio BMY Stock Details BMY Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2017 Q2	$2.35M	Sell	42,189 -1,735	-4%	-$94.4K	0.07%	353
2017 Q1	$2.39M	Buy	43,924 +970	+2%	+$53.2K	0.07%	352
2016 Q4	$2.51M	Buy	42,954 +3,342	+8%	+$183K	0.07%	321
2016 Q3	$2.14M	Buy	39,612 +3,920	+11%	+$252K	0.06%	370
2016 Q2	$2.63M	Buy	35,692 +1,945	+6%	+$137K	0.08%	300
2016 Q1	$2.16M	Buy	33,747 +2,870	+9%	+$181K	0.06%	368
2015 Q4	$2.12M	Buy	30,877 +2,950	+11%	+$195K	0.06%	377
2015 Q3	$1.65M	Buy	27,927 +805	+3%	+$51.1K	0.05%	415
2015 Q2	$1.8M	Sell	27,122 -130	-0.5%	-$8.57K	0.05%	408
2015 Q1	$1.76M	Buy	27,252 +2,895	+12%	+$181K	0.05%	437
2014 Q4	$1.44M	Sell	24,357 -1,250	-5%	-$70.5K	0.04%	490
2014 Q3	$1.31M	Buy	25,607 +1,240	+5%	+$61.9K	0.04%	463
2014 Q2	$1.18M	Sell	24,367 -37,686	-61%	-$1.86M	0.04%	539
2014 Q1	$3.22M	Sell	62,053 -44,291	-42%	-$2.36M	0.1%	235
2013 Q4	$5.65M	Sell	106,344 -90,648	-46%	-$4.62M	0.16%	141
2013 Q3	$9.12M	Sell	196,992 -10,355	-5%	-$455K	0.22%	87
2013 Q2	$9.27M	Buy	+207,347	New	+$9M	0.24%	75

Other funds holding BMY

Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return

Capital World Investors Los Angeles, California $733B AUM 35.63% 1-Year Est. Return

Dodge & Cox San Francisco, California $182B AUM 14.68% 1-Year Est. Return

Northern Trust Chicago, Illinois $757B AUM 28.64% 1-Year Est. Return

Jennison Associates New York $145B AUM 34.61% 1-Year Est. Return

JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return

Capstone Asset Management's BMY Position: Q2 2017 in Review

Capstone Asset Management reduced its Bristol-Myers Squibb (BMY) stake by 4% in Q2 2017, selling an estimated $94.4K and leaving 42,189 shares worth $2.35M. The position accounts for 0.07% of the portfolio, ranked #353.

Capstone Asset Management first reported a position in BMY in Q2 2013 and has held it in 17 quarters since. The position peaked at $9.27M in Q2 2013. 1,594 funds tracked by Wall St. Rank hold BMY as of Q2 2017.

Capstone Asset Management held 42,189 shares of Bristol-Myers Squibb worth $2.35M as of Q2 2017.
Capstone Asset Management sold 1,735 Bristol-Myers Squibb shares in Q2 2017, an estimated $94.4K.
Bristol-Myers Squibb made up 0.07% of Capstone Asset Management's portfolio in Q2 2017, its #353 holding.
Capstone Asset Management first reported a position in Bristol-Myers Squibb in Q2 2013 and has held it in 17 quarters since.
Capstone Asset Management's Bristol-Myers Squibb position peaked at $9.27M in Q2 2013.
1,594 funds tracked by Wall St. Rank held Bristol-Myers Squibb as of Q2 2017.

Based on Capstone Asset Management's 13F filing for Q2 2017, filed 10 Jul 2017.